| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |